Skyepharma Cash Flow - Annual (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

The financial analysis of SKYEY requires an investor to check the cash flows for Skyepharma. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Skyepharma profits one has to check the income statement and for Skyepharma debt one has to check the balance sheet. Skyepharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Skyepharma had cash and cash equivalents of $49.53M at the beginning of the year and $62.83M at year end for 2015. The cash from operating activities for Skyepharma is $ 2015, which saw a decrease from previous year.

View details of Skyepharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Net Income Cash Flow
40.21M-17.3M1.25M-6.97M-2.56M9.74M-2.19M-53.23M
Depreciation Depletion Amortization Cash-Flow4.28M5.27M6.72M4.75M4.33M5.1M5.48M10.01M
Net Increase (Decrease) in Assets Liabilities-14.37M4.94M-3.91M--2.72M14.68M-9.08M-17.8M
Cash From (used in) Discontinued Operations----9.82M----
Other Adjustments Net8.4M56.36M18.15M40.89M20.69M11.44M32.1M69.37M
Net Cash from (used by) Operating Activities
38.52M49.27M22.22M29M19.73M40.97M26.3M8.34M
Increase (Decrease) in Prop Plant And Equipment-5.35M-1.81M-3.59M-0.79M-3.85M-6.49M-7.51M-7.79M
Acquisition Disposition of Subsidiaires---9.82M----
Increase (Decrease) in Investments--------
Other Cash Inflow (Outflow) from Investment Activities-1.37M-2.8M-1.56M-0.31M---0.15M1.48M
Net Cash from (used by) Investment Activities
-6.72M-4.61M-5.16M8.71M-3.85M-6.18M-7.67M-6.3M
Issuance (Purchase) of Equity Shares-184.58M-----34.13M
Issuance (Repayment) of Debt Securities-17.27M-184.09M-11.11M-20.13M-19.73M-15.92M-10.96M-
Increase (Decrease) in Bank & Other Borrowings--------5.56M
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities-2.59M-18.78M-5.78M-15.53M-18.45M-18.09M-19.73M-32.46M
Net Cash from (used by) Financing Activities
-19.87M-18.29M-16.89M-35.66M-38.18M-34.01M-30.69M-3.89M
Effect of Exchange Rate Changes on Cash1.37M-0.16M--0.15M-2.93M-1.25M8.9M
Net Change in Cash & Cash Equivalents
13.3M27.19M-1.9M-21.98M2.93M-13.31M7.04M
Cash & Equivalents at Beginning of Year49.53M26.2M25.66M24.09M46.36M41.75M55.58M58.8M
Cash & Equivalents at Year End62.83M53.39M25.81M25.99M24.38M44.68M42.27M65.85M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Skyepharma stock price history and Skyepharma stock comparison chart inevitably reflect its cash flow situation.

  • Skyepharma has cash of $62.83M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Skyepharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Skyepharma gained $38.52M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: Skyepharma used $-6.72M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-19.87M for Skyepharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.